Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Supplementary_Table_1 - FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

Autor: Kieffer, Cameron M., Miller, Alexis Reisin, Chacko, Benjamin, Robertson, Andrew S.

Supplemental Material, Supplementary_Table_1 for FDA Reported Use of Patient Experience Data in 2018 Drug Approvals by Cameron M. Kieffer, Alexis Reisin Miller, Benjamin Chacko and Andrew S. Robertson in Therapeutic Innovation & Regulatory Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492a0832f65d28b4194349476245c74a

FDA Reported Use of Patient Experience Data in 2018 Drug Approvals

Autor: Kieffer, Cameron M., Miller, Alexis Reisin, Chacko, Benjamin, Robertson, Andrew S.

Publikováno v: Therapeutic Innovation and Regulatory Science; 20240101, Issue: Preprints

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FDA Reported Use of Patient Experience Data in 2018 Drug Approvals.

Autor: Kieffer CM; Global Regulatory Science and Policy, NA, Sanofi, Bethesda, Maryland, USA., Miller AR; Global Regulatory Science and Policy, NA, Sanofi, Bethesda, Maryland, USA., Chacko B; Global Regulatory Science and Policy, NA, Sanofi, Bethesda, Maryland, USA., Robertson AS; Global Regulatory Science and Policy, NA, Sanofi, Bethesda, Maryland, USA.

Publikováno v: Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2019 Oct 09, pp. 2168479019871519. Date of Electronic Publication: 2019 Oct 09.